Because distinctive biological behavior of rectal cancer and scarce GCC expression in rectal cancer were reported, we selected GCC as a special biomarker in tumor tissues and circulation in rectal cancer patients without distant metastasis, for designating GCC as a CRC-specific biomarker in future applications. The gene discussed is GUCY2C; the disease is colorectal carcinoma.